GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pharma Aids Ltd (DHA:PHARMAID) » Definitions » EPS (Basic)

Pharma Aids (DHA:PHARMAID) EPS (Basic) : BDT17.01 (TTM As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Pharma Aids EPS (Basic)?

Pharma Aids's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was BDT4.45. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT17.01.

Pharma Aids's EPS (Diluted) for the three months ended in Mar. 2025 was BDT4.45. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT17.01.

Pharma Aids's EPS without NRI for the three months ended in Mar. 2025 was BDT4.45. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 16.88.

During the past 12 months, Pharma Aids's average EPS without NRIGrowth Rate was 3.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Pharma Aids's highest 3-Year average EPS without NRI Growth Rate was 75.60% per year. The lowest was -50.00% per year. And the median was 18.30% per year.


Pharma Aids EPS (Basic) Historical Data

The historical data trend for Pharma Aids's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Aids EPS (Basic) Chart

Pharma Aids Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.82 16.11 11.14 -2.05 19.61

Pharma Aids Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.46 1.24 5.66 5.66 4.45

Pharma Aids EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pharma Aids's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(61.187-0)/3.120
=19.61

Pharma Aids's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(13.892-0)/3.120
=4.45

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT17.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Aids  (DHA:PHARMAID) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pharma Aids EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Pharma Aids's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Aids Business Description

Traded in Other Exchanges
N/A
Address
345 Segun Bagicha, 1st Floor, Ramna, Dhaka, BGD, 1000
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).

Pharma Aids Headlines

No Headlines